Study of subcellular localization and proteolysis of ataxin-3.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Neurobiology of Disease

• Publication date

  2008-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.nbd.2008.01.011PMID 18353661
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Calpain Inhibition Is Sufficient to Suppress Aggregation of Polyglutamine-expanded Ataxin-3*

  2007cited by this paper
• Cellular Turnover of the Polyglutamine Disease Protein Ataxin-3 Is Regulated by Its Catalytic Activity*

  2007cited by this paper
• A Mutant ataxin-3 fragment results from processing at a site N-terminal to amino acid 190 in brain of Machado–Joseph disease-like transgenic mice

  2007cited by this paper
• Polyglutamine expansion inhibits respiration by increasing reactive oxygen species in isolated mitochondria.

  2006cited by this paper
• An arginine/lysine‐rich motif is crucial for VCP/p97‐mediated modulation of ataxin‐3 fibrillogenesis

  2006cited by this paper
• Structure validation of the Josephin domain of ataxin-3: Conclusive evidence for an open conformation

  2006cited by this paper
• Proteolytic cleavage of polyglutamine-expanded ataxin-3 is critical for aggregation and sequestration of non-expanded ataxin-3.

  2006cited by this paper
• The role of mitochondria in inherited neurodegenerative diseases

  2006cited by this paper
• Ataxin‐3 is subject to autolytic cleavage

  2006cited by this paper
• Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates.

  2006cited by this paper
• The solution structure of the Josephin domain of ataxin-3: structural determinants for molecular recognition.

  2005cited by this paper
• Deubiquitinating function of ataxin-3: insights from the solution structure of the Josephin domain.

  2005cited by this paper
• Defining the Role of Ubiquitin-interacting Motifs in the Polyglutamine Disease Protein, Ataxin-3*

  2005cited by this paper
• Inefficient degradation of truncated polyglutamine proteins by the proteasome

  2004cited by this paper
• Caspase‐mediated proteolysis of the polyglutamine disease protein ataxin‐3

  2004cited by this paper
• A Mutant Ataxin-3 Putative-Cleavage Fragment in Brains of Machado-Joseph Disease Patients and Transgenic Mice Is Cytotoxic above a Critical Concentration

  2004cited by this paper
• Structural and functional analysis of ataxin-2 and ataxin-3.

  2004cited by this paper
• Molecular clearance of ataxin‐3 is regulated by a mammalian E4

  2004cited by this paper
• Elucidation of ataxin-3 and ataxin-7 function by integrative bioinformatics.

  2003cited by this paper
• Domain architecture of the polyglutamine protein ataxin‐3: a globular domain followed by a flexible tail

  2003cited by this paper
• The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity.

  2003cited by this paper
• Ataxin-3 Interactions with Rad23 and Valosin-Containing Protein and Its Associations with Ubiquitin Chains and the Proteasome Are Consistent with a Role in Ubiquitin-Mediated Proteolysis

  2003cited by this paper
• Role of proteolysis in polyglutamine disorders

  2003cited by this paper
• Structural Instability and Fibrillar Aggregation of Non-expanded Human Ataxin-3 Revealed under High Pressure and Temperature*

  2003cited by this paper
• Structural modeling of ataxin‐3 reveals distant homology to adaptins

  2002cited by this paper
• Aggregate formation inhibits proteasomal degradation of polyglutamine proteins.

  2002cited by this paper
• Ataxin-3 Is a Histone-binding Protein with Two Independent Transcriptional Corepressor Activities*

  2002cited by this paper
• Differential susceptibility of cultured cell lines to aggregate formation and cell death produced by the truncated Machado-Joseph disease gene product with an expanded polyglutamine stretch.

  2001cited by this paper
• An expanded glutamine repeat destabilizes native ataxin-3 structure and mediates formation of parallel β-fibrils

  2001cited by this paper
• Polyglutamine‐induced ion channels: a possible mechanism for the neurotoxicity of huntington and other CAG repeat diseases

  2000cited by this paper
• Heterogeneous intracellular localization and expression of ataxin-3.

  1998cited by this paper
• Caspase Cleavage of Gene Products Associated with Triplet Expansion Disorders Generates Truncated Fragments Containing the Polyglutamine Tract*

  1998cited by this paper
• Ataxin-3 is transported into the nucleus and associates with the nuclear matrix.

  1998cited by this paper
• Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3.

  1997cited by this paper
• Expanded polyglutamine in the Machado–Joseph disease protein induces cell death in vitro and in vivo

  1996cited by this paper

• Molecular hallmarks of neurodegeneration in polyglutamine spinocerebellar ataxias

  2025cites this paper
• Predicting Which Mitophagy Proteins Are Dysregulated in Spinocerebellar Ataxia Type 3 (SCA3) Using the Auto-p2docking Pipeline

  2025cites this paper
• Polyglutamine disorders: Pathogenesis and potential drug interventions.

  2024cites this paper
• ATXN3 promotes prostate cancer progression by stabilizing YAP

  2023cites this paper
• Mechanisms orchestrating the enzymatic activity and cellular functions of deubiquitinases

  2022cites this paper
• Mitochondrial Dysfunction in Spinocerebellar Ataxia Type 3 Is Linked to VDAC1 Deubiquitination

  2022cites this paper
• KPNB1 modulates the Machado–Joseph disease protein ataxin-3 through activation of the mitochondrial protease CLPP

  2022cites this paper
• MicroRNA-409-3p Targeting at ATXN3 Reduces the Apoptosis of Dopamine Neurons Based on the Profile of miRNAs in the Cerebrospinal Fluid of Early Parkinson’s Disease

  2022cites this paper
• Mutant Ataxin-3–Containing Aggregates (MATAGGs) in Spinocerebellar Ataxia Type 3: Dynamics of the Disorder

  2021cites this paper
• From Pathogenesis to Novel Therapeutics for Spinocerebellar Ataxia Type 3: Evading Potholes on the Way to Translation

  2019cites this paper
• Pueraria lobata and Daidzein Reduce Cytotoxicity by Enhancing Ubiquitin-Proteasome System Function in SCA3-iPSC-Derived Neurons

  2019cites this paper
• Altered Levels of Proteins and Phosphoproteins, in the Absence of Early Causative Transcriptional Changes, Shape the Molecular Pathogenesis in the Brain of Young Presymptomatic Ki91 SCA3/MJD Mouse

  2019cites this paper
• Mitochondrial dysfunction and neurodegenerative proteinopathies: mechanisms and prospects for therapeutic intervention

  2018cites this paper
• Mitochondrial Morphology, Function and Homeostasis Are Impaired by Expression of an N-terminal Calpain Cleavage Fragment of Ataxin-3

  2018cites this paper
• Physiological and pathophysiological characteristics of ataxin-3 isoforms

  2018cites this paper
• A Futile Battle? Protein Quality Control and the Stress of Aging.

  2018cites this paper
• Divalproex sodium modulates nuclear localization of ataxin‐3 and prevents cellular toxicity caused by expanded ataxin‐3

  2018cites this paper
• Mass spectrometry analyses of normal and polyglutamine expanded ataxin‐3 reveal novel interaction partners involved in mitochondrial function

  2018cites this paper
• Experimental and Clinical Strategies for Treating Spinocerebellar Ataxia Type 3.

  2018cites this paper
• Molecular Mechanisms and Cellular Pathways Implicated in Machado-Joseph Disease Pathogenesis.

  2018cites this paper
• With the Help of MOM: Mitochondrial Contributions to Cellular Quality Control.

  2017cites this paper
• Investigation of the multi-domain aggregation mechanism of ataxin-3

  2017cites this paper
• Polyglutamine ataxias: From Clinical and Molecular Features to Current Therapeutic Strategies

  2017cites this paper
• Mitochondrial quality control by mitochondrial ubiquitin ligase MITOL/MARCH5.

  2017cites this paper
• Ataxin-3 promotes genome integrity by stabilizing Chk1

  2017cites this paper
• Proteolytic Cleavage of Polyglutamine Disease-Causing Proteins: Revisiting the Toxic Fragment Hypothesis.

  2017influential citation
• On the linkage between the ubiquitin-proteasome system and the mitochondria.

  2016cites this paper
• Ataxin-3 phosphorylation decreases neuronal defects in spinocerebellar ataxia type 3 models

  2016cites this paper
• Cross Talk of Proteostasis and Mitostasis in Cellular Homeodynamics, Ageing, and Disease

  2016cites this paper
• The Machado–Joseph Disease Deubiquitinase Ataxin-3 Regulates the Stability and Apoptotic Function of p53

  2016cites this paper
• The amazing ubiquitin-proteasome system: structural components and implication in aging.

  2015cites this paper
• Assays to monitor aggrephagy.

  2015cites this paper
• Trehalose alleviates neuropathological and motor behaviour deficits of a transgenic mouse model of Machado-Joseph disease

  2015cites this paper
• Toward therapeutic targets for SCA3: Insight into the role of Machado-Joseph disease protein ataxin-3 in misfolded proteins clearance.

  2015cites this paper
• From Pathways to Targets: Understanding the Mechanisms behind Polyglutamine Disease

  2014cites this paper
• Normal and pathogenic ataxin-3: biological roles, toxicity and fibrillogenesis

  2014cites this paper
• Ataxin-3 Protein and RNA Toxicity in Spinocerebellar Ataxia Type 3: Current Insights and Emerging Therapeutic Strategies

  2013cites this paper
• Conformational Behavior and Aggregation of Ataxin-3 in SDS

  2013cites this paper
• Cerebellar Soluble Mutant Ataxin-3 Level Decreases during Disease Progression in Spinocerebellar Ataxia Type 3 Mice

  2013cites this paper
• Calpain-mediated ataxin-3 cleavage in the molecular pathogenesis of spinocerebellar ataxia type 3 (SCA3).

  2013cites this paper
• Ataxin-3 and Its E3 Partners: Implications for Machado–Joseph Disease

  2013cites this paper
• Ubiquitination Regulates the Neuroprotective Function of the Deubiquitinase Ataxin-3 in Vivo*

  2013cites this paper
• Chapter 479 – Ataxin-3

  2013cites this paper
• in Vivo Deubiquitinase Ataxin-3 Neuroprotective Function of the Ubiquitination Regulates the Neurobiology :

  2013cites this paper
• Valosin-Containing Protein (VCP/p97) Is an Activator of Wild-Type Ataxin-3

  2012cites this paper
• Toward understanding Machado-Joseph disease.

  2012cites this paper
• The Emerging Role of Proteolysis in Mitochondrial Quality Control and the Etiology of Parkinson's Disease

  2012cites this paper
• Calpain-mediated proteolysis of ataxin-3 in Machado-Joseph disease

  2012influential citation
• Model Systems for Spinocerebellar Ataxias: Lessons Learned About the Pathogenesis

  2012cites this paper
• Insights into pathology and neurodegeneration features in a transgenic mouse model of Machado-Joseph disease

  2011cites this paper
• Protein Aggregates Are Recruited to Aggresome by Histone Deacetylase 6 via Unanchored Ubiquitin C Termini

  2011cites this paper
• A mitochondrial ubiquitin ligase MITOL controls cell toxicity of polyglutamine-expanded protein.

  2011cites this paper
• The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability.

  2011cites this paper
• Polyglutamine diseases: the special case of ataxin-3 and Machado-Joseph disease.

  2011cites this paper
• Toxic intermediates and protein quality control in the polyglutamine disease, SCA3

  2010cites this paper
• Ataxin-3 aggregation and its impact on membrane destabilization

  2010cites this paper
• CK 2 and GSK 3 phosphorylation on S 29 controls wild-type ATXN 3 nuclear uptake

  2010cites this paper
• CK2 and GSK3 phosphorylation on S29 controls wild-type ATXN3 nuclear uptake.

  2010cites this paper
• Preventing Ataxin-3 protein cleavage mitigates degeneration in a Drosophila model of SCA3

  2009influential citation
• STUDIES ON THE MECHANISM AND PHYSIOLOGICAL ROLE(S) OF THE INTERACTION OF ATAXIN-3 WITH TUBULIN

  2009influential citation
• Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3

  2009cites this paper
• Identification and functional dissection of localization signals within ataxin-3.

  2009cites this paper
• The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies

  2009cites this paper
• Proteomic and biochemical analyses unveil tight interaction of ataxin-3 with tubulin.

  2009cites this paper
• Mitochondrial abnormalities in spinal and bulbar muscular atrophy

  2008cites this paper